Senior insider sale
Chief Executive Officer at CENTESSA PHARMACEUTICALS PLC — senior position signals high conviction
$1.11M
43.17K shares
What this filing means
ACCARDI MARIO ALBERTO plans to sell 43.17K shares of CENTESSA PHARMACEUTICALS PLC valued at approximately $1.11M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/9/2025ACC: 0001969223-25-001060
DirectorOfficer· Chief Executive Officer
Since Feb 2026
43.17K
Shares to sell
$1.11M
Approx. market value
10K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Founders Shares
NA
1/2/2020
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2020 | Founders Shares NA | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
10K
Market value
$300.0K
12/8/2025
—Completed
Units to sell
8K
Market value
$200.0K
10/27/2025
—Completed
Units to sell
8.17K
Market value
$174.8K
9/16/2025
—Completed
Units to sell
7K
Market value
$140.0K
9/9/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
10K
Market value
$293.0K
12/9/2025
Total
Units
43.17K
Value
$1.11M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/8/2025 | 10K | $300.0K | — | Completed |
10/27/2025 | 8K | $200.0K | — | Completed |
9/16/2025 | 8.17K | $174.8K | — | Completed |
9/9/2025 | 7K | $140.0K | — | Completed |
| Planned — Approximate Date | ||||
12/9/2025 | 10K | $293.0K | NASDAQ | Planned |
| Total | 43.17K | $1.11M | ||